Sebro, R., Levy, H., Schneck, K., Dimmock, D., Raby, B., Cannon, C., . . . Risch, N. (2012). Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency. Clinical Genetics, 82(6), 546. https://doi.org/10.1111/j.1399-0004.2011.01804.x
Chicago Style (17th ed.) CitationSebro, R., H. Levy, K. Schneck, D. Dimmock, BA Raby, CL Cannon, U. Broeckel, and NJ Risch. "Cystic Fibrosis Mutations for P.F508del Compound Heterozygotes Predict Sweat Chloride Levels and Pancreatic Sufficiency." Clinical Genetics 82, no. 6 (2012): 546. https://doi.org/10.1111/j.1399-0004.2011.01804.x.
MLA (9th ed.) CitationSebro, R., et al. "Cystic Fibrosis Mutations for P.F508del Compound Heterozygotes Predict Sweat Chloride Levels and Pancreatic Sufficiency." Clinical Genetics, vol. 82, no. 6, 2012, p. 546, https://doi.org/10.1111/j.1399-0004.2011.01804.x.